Newsletter Subject

Madonna's ICU Stay May Have Been Due to Sepsis

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Jul 1, 2023 11:20 AM

Email Preheader Text

Weekly Review Saturday, July 01, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, July 01, 2023 [Madonna's ICU Stay May Have Been Due to Sepsis]( [Vitamin D for Cardiovascular Prevention Runs Into Another Wall]( [What Do We Know About the EU.1.1 COVID Variant?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma]( [Stanford Study of Paxlovid for Long COVID Stopped Early]( [What Has Mehmet Oz Been Up To?]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Dementia Risk Tied to Menopausal Hormone Therapy, Even in Women 55 and Younger]( CME SPOTLIGHT [Expert Strategies to Monitor and Mitigate Adverse Events During Breast Cancer Treatment]( [When Wegovy Doesn't Work for Weight Loss]( [Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant]( [At $20K, Stem Cell Eye Injections May Also Cost Patients Their Sight]( CME SPOTLIGHT [Clinical Case Challenge: Applying the Latest Evidence to Improve Outcomes in BRAF Mutant Advanced Melanoma]( [Colchicine vs Afib; Winter Spike in Cardiac Arrests; Cardiologist Stabbed at Home]( [The Next CDC Director Could Learn a Thing or Two From Warren Buffett]( [Waste Company's 'Concealed Human Torso' Suit; Impostor Nurse Reportedly Rips Out IVs]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial]( [Opioids No Better for Acute Neck and Back Pain Than Non-Opioid Treatment]( [Lewis Capaldi's Tourette's Episode Shows Adults Can Be Diagnosed, Too]( CME SPOTLIGHT [Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer]( [Clinicians Aren't Always to Blame for Medical Errors]( [WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer]( [Penn Medicine Pulls Out of U.S. News Hospital Rankings]( CME SPOTLIGHT [Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers]( [Intentional COVID Infection Study; Anxiety and Depression Screening]( [MS Disease Severity Tied to Genetic Variant]( [I Am a Physician Face of Affirmative Action]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( [Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial]( [Speech Predicts Alzheimer's; Afib and Dementia in Women; Who Gets Lecanemab?]( [Without Early Detection, Fighting Dementia Is an Uphill Battle]( CME SPOTLIGHT [Expert Approaches to the Treatment and Management of Cytomegalovirus (CMV) in Transplant Recipients]( [The Dangerous Reality of Pregnancy in the U.S.]( [Malpractice Lawsuits Over Denied Abortion Care May Be on the Horizon]( [BMI Alone Falling Out of Favor as a Way to Assess Healthy Weight]( [Fecal Matter Transplant Shows Promise in Cirrhosis]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-07-01&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.